Virus News and Research

Latest Virus News and Research

High prevalence of persistent cardiovascular symptoms in COVID-19 recovered patients according to new study

Scientists recently conducted a study on community-dwelling adults to determine the prevalence and risk factors of long-term cardiovascular symptoms in COVID-19 recovered individuals.

8 Jul 2022

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

A recent study reported that long COVID in mice causes brain inflammation and cognitive impairment.

8 Jul 2022

Vaccine and testing delays for monkeypox echo failures in early covid response

Andy Stone is one of the lucky ones. The New York City resident saw a tweet from a local AIDS activist saying that monkeypox vaccines would be available that day at a clinic in Manhattan

8 Jul 2022

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.

8 Jul 2022

Research assesses antigenic co-evolution of SARS-CoV-2 variants

In a recent study posted to the bioRxiv* preprint server, researchers analyzed antigenic variety across the significant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, like Omicron lineages.

8 Jul 2022

Antibodies transmitted through breast milk persist six months after COVID mRNA vaccination

Researchers describe the effects of COVID-19 vaccines in lactating mothers and relates their antibody response to the protection of their children.

7 Jul 2022

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

In a recent study posted to the medRxiv* preprint server, researchers assessed the efficacy and durability of immune responses to the third dose of coronavirus disease 2019 (COVID-19) vaccines. They also assessed the efficacy of the fourth vaccine dose among severely immunocompromised patients with hematological malignancies.

7 Jul 2022

What is the monkeypox transmission risk in metropolitan areas?

A new study discusses the possible patterns of spread of monkeypox, and strategies to contain such transmission.

7 Jul 2022

Novel COVID-19 antibody delivery approach advances to clinical trials

Under a Defense Advanced Research Projects Agency (DARPA) and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) funded program, a novel COVID-19 antibody delivery approach has advanced to clinical trials.

7 Jul 2022

Asymptomatic monkeypox infection detected from routine sexual health samples

A new study reports on the incidence of subclinical monkeypox infection among individuals attending a sexual health clinic in Belgium.

7 Jul 2022

Knowledge of HIV Pol polyprotein's structure could spur the development of new therapies

In a discovery that could spur the development of new therapies for more than 40 million HIV patients worldwide, scientists from Rutgers University and the Salk Institute determined the molecular structure of the HIV Pol polyprotein, a protein that plays a critical role in helping the virus propagate itself and spread throughout the body.

7 Jul 2022

Neuropsychiatric symptoms prevalent in over 50% of monkeypox infections according to new research

Scientists have recently conducted a systematic review and meta-analysis to assess the types and prevalence of neurological and psychiatric symptoms associated with monkeypox virus infection in humans.

7 Jul 2022

Study examines IMPACC trial results to understand clinical phenotypes of disease severity in hospitalized COVID-19 patients

In a recent article, longitudinal clinical phenotypes were described based on respiratory ordinal scales.

7 Jul 2022

Broadness of neutralizing antibodies to sarbecoviruses depends on priming conditions

In a recent study under review at the Nature Portfolio journal and currently available on the Research Square* preprint server, researchers identified immune priming conditions that generated broadly neutralizing antibody (nAb) responses and assessed immunity post-third dose of coronavirus disease 2019 (COVID-19) vaccines such as BNT126b2 or Coronavac vaccines after two homologous doses of BNT126b2 or Coronavac vaccines.

7 Jul 2022

2022 monkeypox presents with new symptoms

In a recent study published in The Lancet Infectious Diseases, researchers described the clinical and demographical characteristics of monkeypox virus infections among individuals attending sexual health centers in the United Kingdom (UK).

6 Jul 2022

SARS-CoV-2 RBD vulnerability discovered - target for antibodies against variants

A new study successfully identified a potent neutralization epitope in SARS-related coronaviruses.

6 Jul 2022

Study offers insights into potentially problematic interactions between viruses and live vaccines

A study of a herpes virus that infects chickens offers new insights into potentially problematic interactions between vaccines made from live viruses and the viruses they are meant to thwart.

6 Jul 2022

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system's history with other coronaviruses, including those behind the common cold, shapes the patient's response, according to a study published today in Cell Reports.

6 Jul 2022

Vaccination against smallpox efficiently protects against monkeypox infection

In a new study, researchers assessed the existing information regarding monkeypox infections.

6 Jul 2022

Researchers reveal the exceptional capacity of Omicron to evade the immune system

The current wave of COVID-19 highlights a particularly high risk of reinfection by the Omicron variant of SARS-CoV-2.

6 Jul 2022

Virus News and Research

Latest Virus News and Research

High prevalence of persistent cardiovascular symptoms in COVID-19 recovered patients according to new study

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

Vaccine and testing delays for monkeypox echo failures in early covid response

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

Research assesses antigenic co-evolution of SARS-CoV-2 variants

Antibodies transmitted through breast milk persist six months after COVID mRNA vaccination

After 3 doses of COVID vaccine, most cancer patients retain detectable humoral immunity

What is the monkeypox transmission risk in metropolitan areas?

Novel COVID-19 antibody delivery approach advances to clinical trials

Asymptomatic monkeypox infection detected from routine sexual health samples

Knowledge of HIV Pol polyprotein's structure could spur the development of new therapies

Neuropsychiatric symptoms prevalent in over 50% of monkeypox infections according to new research

Study examines IMPACC trial results to understand clinical phenotypes of disease severity in hospitalized COVID-19 patients

Broadness of neutralizing antibodies to sarbecoviruses depends on priming conditions

2022 monkeypox presents with new symptoms

SARS-CoV-2 RBD vulnerability discovered - target for antibodies against variants

Study offers insights into potentially problematic interactions between viruses and live vaccines

Vaccine generates antibodies that target SARS-CoV-2 spike protein regions shared among many coronaviruses

Vaccination against smallpox efficiently protects against monkeypox infection

Researchers reveal the exceptional capacity of Omicron to evade the immune system

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in